The optogenetics market size has grown rapidly in recent years. It will grow from $40.9 billion in 2025 to $47.13 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to advancements in genetic engineering tools, increased neuroscience research funding, adoption of optical stimulation techniques, growth of academic and laboratory research, improvements in optical sensor sensitivity.
The optogenetics market size is expected to see rapid growth in the next few years. It will grow to $81.05 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing use of optogenetics in disease research, rising investments in brain research initiatives, expansion of translational neuroscience studies, growing integration with ai-based data analysis, continuous development of advanced optical actuators. Major trends in the forecast period include increasing adoption of light-based neural control techniques, rising use of genetically encoded optical sensors, growing integration of optogenetics with neuroscience research, expansion of behavioral and neural circuit mapping studies, enhanced focus on precision neuromodulation.
The optogenetics market is also fueled by increased funding for neuroscience research, which involves the scientific study of the nervous system, including the brain and peripheral nerves. Optogenetics, a cutting-edge technique in neuroscience, utilizes light to precisely control and manipulate specific neurons in living tissues, providing researchers with a powerful tool to understand neural circuits. In March 2023, the National Institutes of Health (NIH) reported approximately $11.3 billion in funding for neuroscience in fiscal year 2022, with projections indicating an expected increase to $12.1 billion by 2023. This increased funding is expected to drive the growth of the optogenetics market.
Major players in the optogenetics space are increasingly prioritizing the development of advanced solutions such as compact femtosecond lasers to enhance imaging resolution, improve experimental precision, and enable sophisticated optogenetic applications. Femtosecond lasers are ultrafast laser systems that emit extremely short pulses, allowing highly precise neural stimulation and high-resolution imaging while minimizing thermal damage to tissue. For example, in June 2025, Coherent, Inc., a United States-based photonics company, introduced the Osprey, a compact femtosecond laser designed for use in optogenetics, microsurgery, and medical device manufacturing. The Osprey delivers pulse energies of up to 5 microjoules with sub-350 femtosecond pulse durations, providing high beam quality, excellent pointing stability, and a robust design suitable for integration into advanced microscopy platforms and medical instrumentation.
In February 2025, Verana Health, a United States-based digital health company focused on real-world data and analytics, entered into a partnership with Nanoscope Therapeutics to accelerate research in retinitis pigmentosa by leveraging Verana’s Qdata Retinitis Pigmentosa dataset comprising more than 70,000 de-identified patient records. Under this collaboration, Nanoscope will utilize real-world evidence to improve patient stratification, optimize clinical trial design, and support the clinical development and commercialization of its MCO-010 optogenetic gene therapy for inherited retinal degeneration. Nanoscope Therapeutics is a United States-based biotechnology company developing gene-agnostic, vision-restoring optogenetic therapies for patients with advanced retinal degenerative disorders.
Major companies operating in the optogenetics market are Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Merck KGaA, The Jackson Laboratory, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems.
North America was the largest region in the optogenetics market in 2025. The regions covered in the optogenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the optogenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the optogenetics market by increasing costs of imported lasers, optical sensors, genetic tools, and precision laboratory equipment used in research and clinical studies. Research institutions in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces higher costs in equipment procurement. These tariffs are increasing research expenses and extending project timelines. However, they are also encouraging local equipment development, regional manufacturing, and innovation in cost-effective optogenetic tools.
The optogenetics market research report is one of a series of new reports that provides optogenetics market statistics, including optogenetics industry global market size, regional shares, competitors with a optogenetics market share, detailed optogenetics market segments, market trends and opportunities, and any further data you may need to thrive in the optogenetics industry. This optogenetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Optogenetics is a comprehensive technique that combines optical systems and genetic engineering technologies to precisely regulate and monitor biological processes within cells, groups of cells, tissues, or organs with high temporal and spatial resolution. This technique is primarily used to monitor and control the physiological activity of neurons and other cell types, employing light sensors. Optogenetics plays a crucial role in identifying the underlying causes of various conditions such as Parkinson's disease, memory disorders, anxiety, addiction issues, mood swings, and other ailments.
The main products associated with optogenetics include lasers, actuators, and sensors. A laser is a device that emits light through a process of optical amplification at specific wavelengths, producing a very narrow beam of light. These products find various applications in neuroscience, behavioral tracking, retinal disease treatment, and other related fields. End-users of optogenetics products include hospitals and clinics, diagnostics centers, research centers, and other institutions involved in scientific and medical research.
The optogenetics market consists of sales of optical cannula, fiber-optic cable, and light sources. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The optogenetics market size is expected to see rapid growth in the next few years. It will grow to $81.05 billion in 2030 at a compound annual growth rate (CAGR) of 14.5%. The growth in the forecast period can be attributed to increasing use of optogenetics in disease research, rising investments in brain research initiatives, expansion of translational neuroscience studies, growing integration with ai-based data analysis, continuous development of advanced optical actuators. Major trends in the forecast period include increasing adoption of light-based neural control techniques, rising use of genetically encoded optical sensors, growing integration of optogenetics with neuroscience research, expansion of behavioral and neural circuit mapping studies, enhanced focus on precision neuromodulation.
The optogenetics market is also fueled by increased funding for neuroscience research, which involves the scientific study of the nervous system, including the brain and peripheral nerves. Optogenetics, a cutting-edge technique in neuroscience, utilizes light to precisely control and manipulate specific neurons in living tissues, providing researchers with a powerful tool to understand neural circuits. In March 2023, the National Institutes of Health (NIH) reported approximately $11.3 billion in funding for neuroscience in fiscal year 2022, with projections indicating an expected increase to $12.1 billion by 2023. This increased funding is expected to drive the growth of the optogenetics market.
Major players in the optogenetics space are increasingly prioritizing the development of advanced solutions such as compact femtosecond lasers to enhance imaging resolution, improve experimental precision, and enable sophisticated optogenetic applications. Femtosecond lasers are ultrafast laser systems that emit extremely short pulses, allowing highly precise neural stimulation and high-resolution imaging while minimizing thermal damage to tissue. For example, in June 2025, Coherent, Inc., a United States-based photonics company, introduced the Osprey, a compact femtosecond laser designed for use in optogenetics, microsurgery, and medical device manufacturing. The Osprey delivers pulse energies of up to 5 microjoules with sub-350 femtosecond pulse durations, providing high beam quality, excellent pointing stability, and a robust design suitable for integration into advanced microscopy platforms and medical instrumentation.
In February 2025, Verana Health, a United States-based digital health company focused on real-world data and analytics, entered into a partnership with Nanoscope Therapeutics to accelerate research in retinitis pigmentosa by leveraging Verana’s Qdata Retinitis Pigmentosa dataset comprising more than 70,000 de-identified patient records. Under this collaboration, Nanoscope will utilize real-world evidence to improve patient stratification, optimize clinical trial design, and support the clinical development and commercialization of its MCO-010 optogenetic gene therapy for inherited retinal degeneration. Nanoscope Therapeutics is a United States-based biotechnology company developing gene-agnostic, vision-restoring optogenetic therapies for patients with advanced retinal degenerative disorders.
Major companies operating in the optogenetics market are Elliot Scientific Ltd., Shanghai Laser & Optics Century Co. Ltd., GenSight Biologics, Coherent Inc., Thorlabs Inc., Prizmatix Ltd., Bruker Corporation, Merck KGaA, The Jackson Laboratory, Applied Genetic Technologies Corporation, Circuit Therapeutics Inc., Bionic Sight LLC, Teledyne Photometrics, Campden Instruments, Nanoscope Therapeutics Inc., Laserglow Technologies, Hubner Group, Physical Sciences Inc., Ray Therapeutics, OptoGenTech, opto biolabs, Neurolux, Ugenex Therapeutics, Scientifica, Cobolt Inc., Inscopix, Mightex Systems.
North America was the largest region in the optogenetics market in 2025. The regions covered in the optogenetics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the optogenetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the optogenetics market by increasing costs of imported lasers, optical sensors, genetic tools, and precision laboratory equipment used in research and clinical studies. Research institutions in North America and Europe are most affected due to reliance on specialized imported components, while Asia-Pacific faces higher costs in equipment procurement. These tariffs are increasing research expenses and extending project timelines. However, they are also encouraging local equipment development, regional manufacturing, and innovation in cost-effective optogenetic tools.
The optogenetics market research report is one of a series of new reports that provides optogenetics market statistics, including optogenetics industry global market size, regional shares, competitors with a optogenetics market share, detailed optogenetics market segments, market trends and opportunities, and any further data you may need to thrive in the optogenetics industry. This optogenetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Optogenetics is a comprehensive technique that combines optical systems and genetic engineering technologies to precisely regulate and monitor biological processes within cells, groups of cells, tissues, or organs with high temporal and spatial resolution. This technique is primarily used to monitor and control the physiological activity of neurons and other cell types, employing light sensors. Optogenetics plays a crucial role in identifying the underlying causes of various conditions such as Parkinson's disease, memory disorders, anxiety, addiction issues, mood swings, and other ailments.
The main products associated with optogenetics include lasers, actuators, and sensors. A laser is a device that emits light through a process of optical amplification at specific wavelengths, producing a very narrow beam of light. These products find various applications in neuroscience, behavioral tracking, retinal disease treatment, and other related fields. End-users of optogenetics products include hospitals and clinics, diagnostics centers, research centers, and other institutions involved in scientific and medical research.
The optogenetics market consists of sales of optical cannula, fiber-optic cable, and light sources. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Optogenetics Market Characteristics
3. Optogenetics Market Supply Chain Analysis
4. Global Optogenetics Market Trends and Strategies
5. Optogenetics Market Analysis of End Use Industries
7. Global Optogenetics Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Optogenetics Total Addressable Market (TAM) Analysis for the Market
9. Optogenetics Market Segmentation
10. Optogenetics Market Regional and Country Analysis
11. Asia-Pacific Optogenetics Market
12. China Optogenetics Market
13. India Optogenetics Market
14. Japan Optogenetics Market
15. Australia Optogenetics Market
16. Indonesia Optogenetics Market
17. South Korea Optogenetics Market
18. Taiwan Optogenetics Market
19. South East Asia Optogenetics Market
20. Western Europe Optogenetics Market
21. UK Optogenetics Market
22. Germany Optogenetics Market
23. France Optogenetics Market
24. Italy Optogenetics Market
25. Spain Optogenetics Market
26. Eastern Europe Optogenetics Market
27. Russia Optogenetics Market
28. North America Optogenetics Market
29. USA Optogenetics Market
30. Canada Optogenetics Market
31. South America Optogenetics Market
32. Brazil Optogenetics Market
33. Middle East Optogenetics Market
34. Africa Optogenetics Market
36. Optogenetics Market Competitive Landscape and Company Profiles
37. Optogenetics Market Other Major and Innovative Companies
40. Optogenetics Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Optogenetics Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses optogenetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for optogenetics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The optogenetics market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product: Lasers; Actuators; Sensors2) By Application: Neuroscience; Behavioral Tracking; Retinal Disease Treatment; Other Applications
3) By End User: Hospitals And Clinics; Diagnostics Centers; Research Centers; Other End Users
Subsegments:
1) By Lasers: Continuous Wave Lasers; Pulsed Lasers; Fiber-Coupled Lasers2) By Actuators: Channelrhodopsins; Halorhodopsins; Opto-xRs
3) By Sensors: Calcium Sensors; Voltage Sensors; Genetically Encoded Indicators
Companies Mentioned: Elliot Scientific Ltd.; Shanghai Laser & Optics Century Co. Ltd.; GenSight Biologics; Coherent Inc.; Thorlabs Inc.; Prizmatix Ltd.; Bruker Corporation; Merck KGaA; The Jackson Laboratory; Applied Genetic Technologies Corporation; Circuit Therapeutics Inc.; Bionic Sight LLC; Teledyne Photometrics; Campden Instruments; Nanoscope Therapeutics Inc.; Laserglow Technologies; Hubner Group; Physical Sciences Inc.; Ray Therapeutics; OptoGenTech; opto biolabs; Neurolux; Ugenex Therapeutics; Scientifica; Cobolt Inc.; Inscopix; Mightex Systems
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Optogenetics market report include:- Elliot Scientific Ltd.
- Shanghai Laser & Optics Century Co. Ltd.
- GenSight Biologics
- Coherent Inc.
- Thorlabs Inc.
- Prizmatix Ltd.
- Bruker Corporation
- Merck KGaA
- The Jackson Laboratory
- Applied Genetic Technologies Corporation
- Circuit Therapeutics Inc.
- Bionic Sight LLC
- Teledyne Photometrics
- Campden Instruments
- Nanoscope Therapeutics Inc.
- Laserglow Technologies
- Hubner Group
- Physical Sciences Inc.
- Ray Therapeutics
- OptoGenTech
- opto biolabs
- Neurolux
- Ugenex Therapeutics
- Scientifica
- Cobolt Inc.
- Inscopix
- Mightex Systems
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 47.13 Billion |
| Forecasted Market Value ( USD | $ 81.05 Billion |
| Compound Annual Growth Rate | 14.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 28 |
